Possible Other Therapeutic Uses of Daprodustat
Daprodustat (Daprodustat) is an oral small-molecule hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI), mainly used for the treatment of chronic kidney disease-related anemia. It inhibits prolyl hydroxylase activity, stabilizes HIF transcription factors, promotes the expression of endogenous erythropoietin, and improves iron metabolism, thereby increasing hemoglobin levels. In addition to its core application in anemia in chronic kidney disease, researchers are gradually turning their attention to other potential therapeutic directions.

In the field of cardiovascular diseases, some studies speculate thatHIF-PHI drugs may improve the hypoxic state in ischemic heart disease or heart failure, although they are still in the basic research and preclinical exploration stages. In oncology, since the HIF pathway is closely related to angiogenesis, daprostat's potential impact on the tumor microenvironment has also caused academic discussion, but its safety and risks require longer-term observation. In addition, plateau hypoxic adaptation and hypoxic symptoms in some patients with chronic lung diseases are also possible directions to explore in the future. Theoretically, by improving the body's red blood cell production and oxygen transport capabilities, dapinostat is expected to play a certain role in these groups.
It should be noted thatHIF pathway is involved in multiple physiological links, including metabolic regulation, immune regulation and vascular homeostasis. Therefore, the expansion of drugs in non-anemia areas needs to be extremely cautious. Currently, daprostat lacks large-scale clinical validation for these potential indications and cannot replace standard treatment. Overall, in addition to its application in renal anemia, dapostat may still show more promise in other hypoxia-related diseases. As research continues, its therapeutic boundaries may be further expanded, but at this stage the core value still lies in anemia management, and other uses are still in the exploratory stage.
Reference materials:https://en.wikipedia.org/wiki/Daprodustat
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)